Stojkovski, I. et al. 2026. SPIRONOLACTONE ORAL SUSPENSION (5 mg/mL): FORMULATION STRATEGIES AND PHYSICOCHEMICAL CHARACTERIZATION. KNOWLEDGE - International Journal . 75, 4 (Mar. 2026), 347–354.